Dr.Sridhar
☆    

2007-10-25 08:10
(6820 d 12:27 ago)

Posting: # 1252
Views: 3,821
 

 Study design - Drugs with Long half life [Design Issues]

Post reply
Dear all,
Why usually
1. sponsors for BE study (drugs with long half life) do not prefer for parallel design, they prefer cross over design.
2. And also sponsors do not prefer truncated study for long half life drugs.

But above are the prefect indications for parallel and truncated study.

regards,
Dr.Sridhar
 
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2007-11-02 19:00
(6812 d 00:37 ago)

@ Dr.Sridhar
Posting: # 1268
Views: 3,020
 

 Study design - Drugs with Long half life

Post reply
Dear Sridhar,

I agree with you to 100%...

Maybe you should hand out the WHO-Guideline to your sponsors (advising them to read Sections 6.2.2, 6.6.2, and especially 6.11.4). :-D
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
 
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
381 visitors (0 registered, 381 guests [including 12 identified bots]).
Forum time: 20:37 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5